test

Mark Gottlieb

@Altium Capital Management Lp

Latest period2024 - Q3ReportedManaged Assets$339.708MTotal holdings77
Assets growth rate-99.86%Assets growth rate (2-Q avg)-51.42%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Altium Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 77 positions.

Assets under management

The assets under management (AUM) of Altium Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 339.708M in assets, with a quarterly growth rate of -99.86% and a 2-quarter average growth rate of -51.42%. The portfolio is managed by Mark Gottlieb, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
OCGNOcugen Inc
Recent Activity
New Position
0.69%
$2.332M
2.35M shares@ $1.0 avg price
MLTXMoonlake Immunotherapeutics
Recent Activity
Decreased -65.21%
0.6%
$2.017M
40,000 shares@ $50.42 avg price
BCYCBicycle Therapeutics Plc
Recent Activity
New Position
0.57%
$1.924M
85,000 shares@ $22.63 avg price
ANVSAnnovis Bio Inc
Recent Activity
Increased 52.23%
0.57%
$1.905M↓ Put
236,400 shares@ $8.06 avg price
VERUVeru Inc
Recent Activity
Decreased -10.89%
0.46%
$1.56M
2.029M shares@ $0.77 avg price
ATRCAtricure Inc
Recent Activity
New Position
0.45%
$1.514M
54,000 shares@ $28.04 avg price
CTMXCytomx Therapeutics Inc
Recent Activity
New Position
0.32%
$1.08M
915,000 shares@ $1.18 avg price
NVNOEnvveno Medical Corporation
Recent Activity
New Position
0.24%
$802,771
238,920 shares@ $3.36 avg price
TPSTTempest Therapeutics Inc
Recent Activity
New Position
0.23%
$763,000
545,000 shares@ $1.4 avg price
PMNPromis Neurosciences Inc
Recent Activity
New Position
0.22%
$726,744
581,395 shares@ $1.26 avg price